Does METOCLOPRAMIDE Cause Agranulocytosis? 34 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 34 reports of Agranulocytosis have been filed in association with METOCLOPRAMIDE (metoclopramide hydrochloride). This represents 0.3% of all adverse event reports for METOCLOPRAMIDE.
34
Reports of Agranulocytosis with METOCLOPRAMIDE
0.3%
of all METOCLOPRAMIDE reports
2
Deaths
17
Hospitalizations
How Dangerous Is Agranulocytosis From METOCLOPRAMIDE?
Of the 34 reports, 2 (5.9%) resulted in death, 17 (50.0%) required hospitalization, and 16 (47.1%) were considered life-threatening.
Is Agranulocytosis Listed in the Official Label?
Yes, Agranulocytosis is listed as a known adverse reaction in the official FDA drug label for METOCLOPRAMIDE.
What Other Side Effects Does METOCLOPRAMIDE Cause?
Nausea (1,080)
Drug ineffective (927)
Off label use (926)
Drug hypersensitivity (751)
Vomiting (672)
Dyspnoea (525)
Headache (499)
Diarrhoea (481)
Hypersensitivity (473)
Tardive dyskinesia (465)
What Other Drugs Cause Agranulocytosis?
CLOZAPINE (1,766)
CYCLOPHOSPHAMIDE (1,242)
RITUXIMAB (1,154)
SULFAMETHOXAZOLE\TRIMETHOPRIM (797)
PANTOPRAZOLE (599)
METHOTREXATE (550)
SODIUM (549)
EPIRUBICIN (491)
METAMIZOLE (438)
DOCETAXEL (436)
Which METOCLOPRAMIDE Alternatives Have Lower Agranulocytosis Risk?
METOCLOPRAMIDE vs METOLAZONE
METOCLOPRAMIDE vs METOPIMAZINE
METOCLOPRAMIDE vs METOPROLOL
METOCLOPRAMIDE vs METRELEPTIN
METOCLOPRAMIDE vs METRONIDAZOLE